Analyst firms · UBS · MS
UBS MS price target and rating history
Morgan Stanley (MS) · Finance
UBS rates Morgan Stanley (MS) Buy with a $196 price target, as of its latest action on Apr 7, 2026. It has published 3 rating actions on MS since January 2022, including 1 upgrade and 1 downgrade. Across 3 firms with a MS price target in the last 12 months, the median target is $210. UBS's $196 is 7% below that.
- Current rating
- Buy
- Price target
- $196
- Median target, all firms
- $210
- Actions on MS
- 3
UBS price target on MS
Every UBS rating on MS
- Apr 7, 2026
- Oct 11, 2023
- Jan 4, 2022
How other firms rate MS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Hold | $210 | Oct 8, 2026 |
| Erste Group | Hold | Oct 8, 2026 | |
| HSBC | Hold | $219 | Sep 28, 2026 |
| Oppenheimer | Underperform | Jun 30, 2026 | |
| UBS | Buy | $196 | Apr 7, 2026 |
| Wolfe Research | Outperform | Nov 24, 2025 |
Questions about UBS and MS
- What is UBS's price target for MS?
- UBS's latest stated price target for Morgan Stanley (MS) is $196, from its action on Apr 7, 2026.
- What is UBS's rating on MS?
- UBS rates MS Buy, a bullish rating, as of Apr 7, 2026.
- When did UBS last change its view on MS?
- On Apr 7, 2026, UBS upgrades to Buy from Neutral, price target $196.
- How does UBS's MS target compare with other analysts?
- Across 3 firms with a MS price target in the last 12 months, the median target is $210. UBS's $196 is 7% below that.
More MS rating histories
- Erste Group4
- HSBC5
- Oppenheimer5
- Wolfe Research3
- Keefe, Bruyette & Woods3
- Wells Fargo4
- Odeon Capital5
- Citigroup3
- RBC Capital Markets3
All UBS ratingsMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.